Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Surgical resection is the only potentially curative treatment for patients with
cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic …

Background: While resection remains the only curative option for perihilar
cholangiocarcinoma, it is well known that such surgery is associated with a high risk of …

Background and aims Up to 40%‐65% of patients with perihilar cholangiocarcinoma (PHC)
rapidly progress to early recurrence (ER) even after curative resection. Quantification of ER …

Background Racial segregation, an effect of historical marginalization, may impact cancer
care and outcomes. We sought to examine the impact of racial segregation on the diagnosis …

Simple Summary Biliary tract cancer is rare in the US but remains a highly lethal cancer.
While the standard of care in the first-line, metastatic setting is well-established, no second …

Background Racial/ethnic disparities in cancer outcomes may relate to variations in receipt
of National Comprehensive Cancer Network (NCCN) guideline compliant care. Patients and …

Background Cholangiocarcinoma is a type of hepatobiliary tumor. For perihilar
cholangiocarcinoma (pCCA), patients who experience early recurrence (ER) have a poor …

Aim The aim of this study is to develop and test radiomics models based on magnetic
resonance imaging (MRI) to preoperatively and respectively predict the T stage, perineural …

Klatskin's tumors, actually-redefined as perihilar cholangiocarcinoma (phCCA) do represent
50–70% of all CCAs and develop in a context of chronic inflammation and cholestasis of bile …